CompletedPhase 2NCT02834260

Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study

Studying Congenital stromal corneal dystrophy

Last synced from ClinicalTrials.gov May 9, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Principal Investigator: Marie Caroline TRONE, MD
Centre Hospitalier Universitaire de Saint Etienne
Intervention: Dexamethasone implant OZURDEX(drug)
Enrollment: 14 enrolled
Eligibility: 18 years · All sexes
Timeline: 2017 – 2019

Study locations (1)

CHU de Saint Etienne, Saint-Etienne, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02834260 on ClinicalTrials.gov

← Back to all trials